These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 36565966)
1. A new class of CYP1B1 inhibitors derived from bentranil. Yi L; Huang X; Yang M; Cai J; Jia J; Peng Z; Zhao Z; Yang F; Qiu D Bioorg Med Chem Lett; 2023 Jan; 80():129112. PubMed ID: 36565966 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of human CYP1 enzymes by a classical inhibitor α-naphthoflavone and a novel inhibitor N-(3, 5-dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study. Juvonen RO; Jokinen EM; Javaid A; Lehtonen M; Raunio H; Pentikäinen OT Chem Biol Drug Des; 2020 May; 95(5):520-533. PubMed ID: 32060993 [TBL] [Abstract][Full Text] [Related]
3. Discovery of heterocycle-containing α-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors. Dong J; Huang G; Cui Q; Meng Q; Li S; Cui J Eur J Med Chem; 2021 Jan; 209():112895. PubMed ID: 33069055 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors. Dong J; Wang Z; Cui J; Meng Q; Li S Eur J Med Chem; 2020 Feb; 187():111938. PubMed ID: 31830634 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and docking studies of trans-stilbene methylthio derivatives as cytochromes P450 family 1 inhibitors. Wierzchowski M; Dutkiewicz Z; Gielara-Korzańska A; Korzański A; Teubert A; Teżyk A; Stefański T; Baer-Dubowska W; Mikstacka R Chem Biol Drug Des; 2017 Dec; 90(6):1226-1236. PubMed ID: 28632937 [TBL] [Abstract][Full Text] [Related]
6. Targeting Cytochrome P450 (CYP) 1B1 Enzyme with Four Series of A-Ring Substituted Estrane Derivatives: Design, Synthesis, Inhibitory Activity, and Selectivity. Dutour R; Roy J; Cortés-Benítez F; Maltais R; Poirier D J Med Chem; 2018 Oct; 61(20):9229-9245. PubMed ID: 30216063 [TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbene. Chun YJ; Oh YK; Kim BJ; Kim D; Kim SS; Choi HK; Kim MY Toxicol Lett; 2009 Aug; 189(1):84-9. PubMed ID: 19463925 [TBL] [Abstract][Full Text] [Related]
8. Aryl morpholino triazenes inhibit cytochrome P450 1A1 and 1B1. Lee D; Perez P; Jackson W; Chin T; Galbreath M; Fronczek FR; Isovitsch R; Iimoto DS Bioorg Med Chem Lett; 2016 Jul; 26(14):3243-3247. PubMed ID: 27265259 [TBL] [Abstract][Full Text] [Related]
9. Novel Synthetic Analogues of 19(S/R)-Hydroxyeicosatetraenoic Acid Exhibit Noncompetitive Inhibitory Effect on the Activity of Cytochrome P450 1A1 and 1B1. Shoieb SM; Dakarapu R; Falck JR; El-Kadi AOS Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):613-624. PubMed ID: 34235626 [TBL] [Abstract][Full Text] [Related]
11. α-naphthoflavone-derived cytochrome P450 (CYP)1B1 degraders specific for sensitizing CYP1B1-mediated drug resistance to prostate cancer DU145: Structure activity relationship. Chen P; Wang S; Cao C; Ye W; Wang M; Zhou C; Chen W; Zhang X; Zhang K; Zhou W Bioorg Chem; 2021 Nov; 116():105295. PubMed ID: 34455300 [TBL] [Abstract][Full Text] [Related]
13. Perspective of structural flexibility on selective inhibition towards CYP1B1 over CYP1A1 by α-naphthoflavone analogs. Wang Y; Hu B; Zhang Y; Wang D; Luo Z; Wang J; Zhang F Phys Chem Chem Phys; 2021 Sep; 23(36):20230-20246. PubMed ID: 34474468 [TBL] [Abstract][Full Text] [Related]
15. In silico guided designing of optimized benzochalcones derivatives as potent CYP1B1 inhibitors: An integrated in vitro and ONIOM study. Sharma H; Raju B; Narendra G; Kumar M; Verma H; Sharma B; Tung GK; Kumar Jain S; Brás NF; Silakari O J Mol Graph Model; 2023 Mar; 119():108390. PubMed ID: 36502606 [TBL] [Abstract][Full Text] [Related]
16. Nitidine Chloride-Induced CYP1 Enzyme Inhibition and Alteration of Estradiol Metabolism. Mao X; Wang J; Wang Q; Yang L; Li Y; Lin H; Peng Y; Zheng J Drug Metab Dispos; 2019 Aug; 47(8):919-927. PubMed ID: 31147316 [TBL] [Abstract][Full Text] [Related]
17. CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1/CYP1B1 inhibitors: Identification of quinazolinones as CYP1A1/CYP1B1 inhibitors that efficiently reverse B[a]P toxicity and cisplatin resistance. Sonawane VR; Siddique MUM; Gatchie L; Williams IS; Bharate SB; Jayaprakash V; Sinha BN; Chaudhuri B Eur J Pharm Sci; 2019 Apr; 131():177-194. PubMed ID: 30776468 [TBL] [Abstract][Full Text] [Related]
18. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives. Shimada T; Tanaka K; Takenaka S; Murayama N; Martin MV; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M Chem Res Toxicol; 2010 Dec; 23(12):1921-35. PubMed ID: 21053930 [TBL] [Abstract][Full Text] [Related]
19. The Activation of Procarcinogens by CYP1A1/1B1 and Related Chemo-Preventive Agents: A Review. Li Y; Cui J; Jia J Curr Cancer Drug Targets; 2021; 21(1):21-54. PubMed ID: 33023449 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of selective CYP1B1 inhibitor via dearomatization of α-naphthoflavone. Kubo M; Yamamoto K; Itoh T Bioorg Med Chem; 2019 Jan; 27(2):285-304. PubMed ID: 30553624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]